GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Curative Biosciences Inc (OTCPK:CBDX) » Definitions » Return-on-Tangible-Asset

Curative Biosciences (Curative Biosciences) Return-on-Tangible-Asset : -12,800.00% (As of Mar. 2018)


View and export this data going back to 2004. Start your Free Trial

What is Curative Biosciences Return-on-Tangible-Asset?

Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. Curative Biosciences's annualized Net Income for the quarter that ended in Mar. 2018 was $-0.13 Mil. Curative Biosciences's average total tangible assets for the quarter that ended in Mar. 2018 was $0.00 Mil. Therefore, Curative Biosciences's annualized Return-on-Tangible-Asset for the quarter that ended in Mar. 2018 was -12,800.00%.

The historical rank and industry rank for Curative Biosciences's Return-on-Tangible-Asset or its related term are showing as below:

CBDX's Return-on-Tangible-Asset is not ranked *
in the Drug Manufacturers industry.
Industry Median: 1.83
* Ranked among companies with meaningful Return-on-Tangible-Asset only.

Curative Biosciences Return-on-Tangible-Asset Historical Data

The historical data trend for Curative Biosciences's Return-on-Tangible-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Curative Biosciences Return-on-Tangible-Asset Chart

Curative Biosciences Annual Data
Trend Jun08 Jun09 Jun10 Jun11 Jun12 Jun13 Jun14 Jun15 Jun16 Jun17
Return-on-Tangible-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only -3,475.39 -46,150.77 -26,952.00 -22,093.33 -1,514.29

Curative Biosciences Quarterly Data
Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18
Return-on-Tangible-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -457.14 -2,880.00 -3,400.00 -120,533.33 -12,800.00

Competitive Comparison of Curative Biosciences's Return-on-Tangible-Asset

For the Drug Manufacturers - Specialty & Generic subindustry, Curative Biosciences's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Curative Biosciences's Return-on-Tangible-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Curative Biosciences's Return-on-Tangible-Asset distribution charts can be found below:

* The bar in red indicates where Curative Biosciences's Return-on-Tangible-Asset falls into.



Curative Biosciences Return-on-Tangible-Asset Calculation

Curative Biosciences's annualized Return-on-Tangible-Asset for the fiscal year that ended in Jun. 2017 is calculated as:

Return-on-Tangible-Asset=Net Income/( (Total Tangible Assets+Total Tangible Assets)/ count )
(A: Jun. 2017 )  (A: Jun. 2016 )(A: Jun. 2017 )
=Net Income/( (Total Assets - Intangible Assets+Total Assets - Intangible Assets)/ count )
(A: Jun. 2017 )  (A: Jun. 2016 )(A: Jun. 2017 )
=-0.053/( (0.005+0.002)/ 2 )
=-0.053/0.0035
=-1,514.29 %

Curative Biosciences's annualized Return-on-Tangible-Asset for the quarter that ended in Mar. 2018 is calculated as:

Return-on-Tangible-Asset=Net Income/( (Total Tangible Assets+Total Tangible Assets)/ count )
(Q: Mar. 2018 )  (Q: Dec. 2017 )(Q: Mar. 2018 )
=Net Income/( (Total Assets - Intangible Assets+Total Assets - Intangible Assets)/ count )
(Q: Mar. 2018 )  (Q: Dec. 2017 )(Q: Mar. 2018 )
=-0.128/( (0.001+0.001)/ 2 )
=-0.128/0.001
=-12,800.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data, the Net Income data used here is four times the quarterly (Mar. 2018) net income data.


Curative Biosciences  (OTCPK:CBDX) Return-on-Tangible-Asset Explanation

Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.


Be Aware

Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the company’s earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a company’s tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).

Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.


Curative Biosciences Return-on-Tangible-Asset Related Terms

Thank you for viewing the detailed overview of Curative Biosciences's Return-on-Tangible-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Curative Biosciences (Curative Biosciences) Business Description

Traded in Other Exchanges
N/A
Address
2 South Biscayne Boulevard, Suite 3760, Miami, FL, USA, 33131
Curative Biosciences Inc is a life sciences company focused on developing and commercializing novel therapeutics using hemp-derived CBD. Its products comprise of CBD softgels, Hemp oil, and Topicals.

Curative Biosciences (Curative Biosciences) Headlines

No Headlines